Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DANIEL D TRUONG

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1992720916
CMS profile
44605
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$10,708.75

251 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Page 4 of 6; records 151–200 of 251 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DANIEL D TRUONG

NPI 1992720916 · CMS profile ID 44605

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 6; records 151–200 of 251 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1992720916?year=2020&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DANIEL D TRUONG, NPI 1992720916, CMS profile ID 44605. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 251 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1992720916?year=2020&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). DANIEL D TRUONG, NPI 1992720916, CMS profile ID 44605. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 251 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1992720916?year=2020&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
DANIEL D TRUONG, NPI 1992720916, CMS profile ID 44605, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 6; records 151–200 of 251 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1992720916?year=2020&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

251 matching records · $10,708.75 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 251 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 251.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $15.4707/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726165225 CMS
Allergan, Inc. $16.8807/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871327 CMS
US WorldMeds, LLC $17.1306/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749589609 CMS
ACADIA Pharmaceuticals Inc $17.4906/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748582035 CMS
Novartis Pharmaceuticals Corporation $1.2906/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726165221 CMS
UCB, Inc. $17.7906/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746065521 CMS
GE HEALTHCARE $16.8606/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743990969 CMS
Teva Pharmaceuticals USA, Inc. $15.0106/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749493259 CMS
Eisai Inc. $16.0906/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751260199 CMS
Novartis Pharmaceuticals Corporation $15.8106/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726165249 CMS
Acorda Therapeutics, Inc $4.4106/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 716704231 CMS
Teva Pharmaceuticals USA, Inc. $15.9206/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749451333 CMS
US WorldMeds, LLC $3.0406/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749589583 CMS
Kyowa Kirin, Inc. $19.3406/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746889667 CMS
Neurocrine Biosciences, Inc. $16.6706/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748941883 CMS
Novartis Pharmaceuticals Corporation $15.0006/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726165219 CMS
Amneal Pharmaceuticals LLC $16.7806/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719990817 CMS
Allergan, Inc. $23.6805/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871325 CMS
Amgen Inc. $16.9505/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740981139 CMS
MERZ NORTH AMERICA, INC. $17.8205/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737045643 CMS
Biogen, Inc. $19.8905/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737255551 CMS
Allergan, Inc. $24.0005/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871323 CMS
Vertical Pharmaceuticals, LLC $16.4305/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741467821 CMS
Sunovion Pharmaceuticals Inc. $19.2305/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748592901 CMS
Upsher-Smith Laboratories LLC $16.0205/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 733041915 CMS
ACADIA Pharmaceuticals Inc $17.3405/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748582033 CMS
Allergan, Inc. $18.1505/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871321 CMS
Kyowa Kirin, Inc. $16.2505/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746889661 CMS
Allergan, Inc. $17.4804/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871319 CMS
Lundbeck LLC $17.8204/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747576899 CMS
Sunovion Pharmaceuticals Inc. $13.8704/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748592889 CMS
Lundbeck LLC $17.8204/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747576897 CMS
Amneal Pharmaceuticals LLC $1,000.0004/21/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719990815 CMS
Amneal Pharmaceuticals LLC $17.1404/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719990813 CMS
Abbott Laboratories $153.2804/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746591683 CMS
Allergan, Inc. $4.7104/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871317 CMS
Allergan, Inc. $9.5403/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871315 CMS
Allergan, Inc. $14.1603/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871313 CMS
Sunovion Pharmaceuticals Inc. $15.6103/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748592895 CMS
Allergan, Inc. $12.5503/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871311 CMS
US WorldMeds, LLC $500.0003/19/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749589459 CMS
Adamas Pharmaceuticals, Inc. $0.3003/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750015749 CMS
Adamas Pharmaceuticals, Inc. $1.3003/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750015751 CMS
Adamas Pharmaceuticals, Inc. $17.1703/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750015753 CMS
Allergan, Inc. $10.5003/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871309 CMS
AbbVie Inc. $17.2103/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722161899 CMS
Allergan, Inc. $5.3703/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871307 CMS
Allergan, Inc. $22.0903/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871305 CMS
Allergan, Inc. $4.2903/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723871303 CMS
Neurocrine Biosciences, Inc. $120.5103/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748941879 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $38,559.74 291
PY2020 $10,708.75 251
PY2021 $14,078.06 355
PY2022 $29,244.06 279
PY2023 $26,387.85 253
PY2024 $5,809.35 250
PY2025 $8,313.58 240

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $185,331.50 34
PY2024 Principal investigator $182,774.45 36
PY2023 Recipient $4,774.99 1
PY2023 Principal investigator $263,413.84 103
PY2022 Principal investigator $184,870.52 51
PY2021 Principal investigator $110,461.25 31
PY2020 Principal investigator $29,895.12 7
PY2019 Recipient $6,548.80 4
PY2019 Principal investigator $78,176.03 34

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

34 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Ipsen Innovation $4,732.28 10/27/2025 Non-covered Recipient Entity
Parkinsons And Movement Disorder Institute
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants No dispute reported 06/30/2026 1184289434
Principal investigator 1 Ipsen Innovation $4,247.60 10/27/2025 Non-covered Recipient Entity
Parkinsons And Movement Disorder Institute
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants No dispute reported 06/30/2026 1184289436
Principal investigator 1 Ipsen Innovation $5,409.88 10/27/2025 Non-covered Recipient Entity
Parkinsons And Movement Disorder Institute
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants No dispute reported 06/30/2026 1184289438
Principal investigator 1 H. Lundbeck A S $3,702.60 09/04/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251774261
Principal investigator 1 H. Lundbeck A S $1,851.30 08/26/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251773958
Principal investigator 1 Ipsen Innovation $15,000.00 08/06/2025 Non-covered Recipient Entity
Parkinsons And Movement Disorder Institute
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants No dispute reported 06/30/2026 1184289430
Principal investigator 1 Ipsen Innovation $2,500.00 08/04/2025 Non-covered Recipient Entity
Parkinsons And Movement Disorder Institute
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants No dispute reported 06/30/2026 1184289432
Principal investigator 1 H. Lundbeck A S $1,851.30 07/31/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251772902
Principal investigator 1 Ipsen Innovation $43.50 07/21/2025 Non-covered Recipient Entity
The Truong Neuroscience Institute
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants No dispute reported 06/30/2026 1184289254
Principal investigator 1 H. Lundbeck A S $2,158.15 07/17/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251772394
Principal investigator 1 H. Lundbeck A S $2,158.15 07/10/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251772064
Principal investigator 1 H. Lundbeck A S $1,851.30 06/24/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251771491
Principal investigator 1 ABBVIE INC. $485.00 06/05/2025 Non-covered Recipient Entity
PARKINSONS AND MOVEMENT DISORDER INSTITUTE
Fixed-Dose Trial in Early Parkinson s Disease (PD) (TEMPO-1) No dispute reported 06/30/2026 1202490577
Principal investigator 1 H. Lundbeck A S $1,851.30 06/05/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251770688
Principal investigator 1 H. Lundbeck A S $1,851.30 05/27/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251770645
Principal investigator 1 H. Lundbeck A S $1,851.30 05/22/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251770580
Principal investigator 1 H. Lundbeck A S $5,438.30 04/15/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251769665
Principal investigator 1 UCB SA $9,433.77 04/14/2025 Non-covered Recipient Entity
PARKINSONS DIS AND MOVEMENT DISORDER INSTITUTE INC
A dose-blinded extension study to evaluate the long-term efficacy, safety, and tolerability of UCB0599 in study participants with Parkinsons disease No dispute reported 06/30/2026 1246659416
Principal investigator 1 Ipsen Innovation $3,733.13 04/04/2025 Non-covered Recipient Entity
Parkinsons And Movement Disorder Institute
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants No dispute reported 06/30/2026 1184289440
Principal investigator 1 Sage Therapeutics, LLC $27,634.00 04/04/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
Study to Evaluate SAGE-324 in Participants With Essential Tremors No dispute reported 06/30/2026 1206580885
Principal investigator 1 H. Lundbeck A S $2,160.00 03/14/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251768757
Principal investigator 1 H. Lundbeck A S $648.00 03/14/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251768760
Principal investigator 1 H. Lundbeck A S $3,702.60 03/11/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251768626
Principal investigator 1 ABBVIE INC. $260.34 02/27/2025 Non-covered Recipient Entity
PARKINSONS AND MOVEMENT DISORDER INSTITUTE
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson s Disease With Motor Fluctuations (TEMPO-3) No dispute reported 06/30/2026 1202455005
Principal investigator 1 ABBVIE INC. $290.00 02/06/2025 Non-covered Recipient Entity
PARKINSONS AND MOVEMENT DISORDER INSTITUTE
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson s Disease With Motor Fluctuations (TEMPO-3) No dispute reported 06/30/2026 1202450070
Principal investigator 1 H. Lundbeck A S $2,160.00 02/06/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251767153
Principal investigator 1 H. Lundbeck A S $648.00 02/06/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251767157
Principal investigator 1 H. Lundbeck A S $3,702.60 02/05/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251767027
Principal investigator 1 H. Lundbeck A S $2,160.00 01/17/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251766566
Principal investigator 1 H. Lundbeck A S $648.00 01/17/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251766569
Principal investigator 1 H. Lundbeck A S $15,765.80 01/15/2025 Non-covered Recipient Entity
THE PARKINSONS AND MOVEMENT DISORDER INSTITUTE
AMULET CLINICAL STUDY PHASE II (INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED) No dispute reported 06/30/2026 1251766535
Principal investigator 1 UCB SA $9,690.00 01/15/2025 Non-covered Recipient Entity
PARKINSON'S & MOVEMENT DISORDERS INSTITUTE
A dose-blinded extension study to evaluate the long-term efficacy, safety, and tolerability of UCB0599 in study participants with Parkinsons disease No dispute reported 06/30/2026 1246657482
Principal investigator 1 UCB SA $1,200.00 01/09/2025 Non-covered Recipient Entity
PARKINSONS DIS AND MOVEMENT DISORDER INSTITUTE INC
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, 18-MONTH PHASE 2A STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ORAL UCB0599 IN STUDY PARTICIPANTS WITH EARLY Parkinsons DISEASE No dispute reported 06/30/2026 1246658540
Principal investigator 1 UCB SA $44,512.00 01/07/2025 Non-covered Recipient Entity
PARKINSONS DIS AND MOVEMENT DISORDER INSTITUTE INC
A MULTICENTER PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF UCB0022 IN STUDY PARTICIPANTS WITH ADVANCED Parkinsons DISEASE No dispute reported 06/30/2026 1246658762